Brawn Biotech Limited (BOM:530207)
India · Delayed Price · Currency is INR 19.00
+0.47 (2.54%)
At close: Jun 17, 2026
Brawn Biotech Market Cap
Brawn Biotech has a market cap or net worth of 59.86 million as of June 18, 2026. Its market cap has increased by 10.04% in one year.
Market Cap
59.86M
Enterprise Value
57.05M
Revenue
169.78M
Ranking
n/a
PE Ratio
6.12
Stock Price
19.00
Market Cap Chart
Since August 11, 2005, Brawn Biotech's market cap has increased from 23.22M to 59.86M, an increase of 157.75%. That is a compound annual growth rate of 4.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 59.86M | -7.25% |
| Dec 31, 2025 | 64.54M | 0.94% |
| Dec 31, 2024 | 63.94M | -2.69% |
| Dec 26, 2023 | 65.71M | 11.17% |
| Dec 30, 2022 | 59.11M | -13.79% |
| Dec 31, 2021 | 68.56M | -6.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 142.51M |
| Ortin Global | 139.45M |
| Emmessar Biotech & Nutrition | 128.65M |
| Shamrock Industrial Company | 127.82M |
| Beryl Drugs | 119.18M |
| Unjha Formulations | 88.27M |
| Ganga Pharmaceuticals | 70.94M |
| Vivanza Biosciences | 68.00M |